Pharmaceuticals
| Year | Client | Period | Income | Expenses | Doc |
|---|---|---|---|---|---|
| 2024 | JAZZ PHARMACEUTICALS, INC. |
1st Quarter (Jan 1 - Mar 31) AMENDED |
— | $510,000 | |
| 2024 | JAZZ PHARMACEUTICALS, INC. |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | $510,000 | |
| 2023 | JAZZ PHARMACEUTICALS, INC. |
4th Quarter (Oct 1 - Dec 31) AMENDED |
— | $690,000 | |
| 2023 | JAZZ PHARMACEUTICALS, INC. |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | $560,000 | |
| 2023 | JAZZ PHARMACEUTICALS, INC. |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— | $640,000 | |
| 2023 | JAZZ PHARMACEUTICALS, INC. |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
— | $640,000 | |
| 2023 | JAZZ PHARMACEUTICALS, INC. |
1st Quarter (Jan 1 - Mar 31) AMENDED |
— | — | |
| 2023 | JAZZ PHARMACEUTICALS, INC. |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | $630,000 | |
| 2023 | JAZZ PHARMACEUTICALS, INC. |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | $630,000 | |
| 2022 | JAZZ PHARMACEUTICALS, INC. |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | $640,000 |
| Client | Filings | Total Income |
|---|---|---|
| JAZZ PHARMACEUTICALS, INC. | 28 | — |
| Name | Disclosed Prior Position |
|---|---|
| MARK BOLTON | |
| KARAS GROSS | FDA - Associate Commissioner for Legislative Affairs (2019-20); House Rules Committee - Deputy Staff Director (2011-19)… |
| VIRGINIA MCMILLIN | Special Assistant to the President (9/2018-12/2020); Health Policy Advisor, Senate Committee on HELP (1/2018-9/2019); S… |